Rigel Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RIGL and other ETFs, options, and stocks.About RIGL
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.
CEORaul R. Rodriguez
CEORaul R. Rodriguez
Employees164
Employees164
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded1996
Founded1996
Employees164
Employees164
RIGL Key Statistics
Market cap758.18M
Market cap758.18M
Price-Earnings ratio6.80
Price-Earnings ratio6.80
Dividend yield—
Dividend yield—
Average volume488.57K
Average volume488.57K
High today$43.40
High today$43.40
Low today$41.71
Low today$41.71
Open price$42.03
Open price$42.03
Volume420.86K
Volume420.86K
52 Week high$52.24
52 Week high$52.24
52 Week low$14.63
52 Week low$14.63
Stock Snapshot
With a market cap of 758.18M, Rigel Pharmaceuticals(RIGL) trades at $41.77. The stock has a price-to-earnings ratio of 6.80.
On 2025-12-19, Rigel Pharmaceuticals(RIGL) stock traded between a low of $41.71 and a high of $43.40. Shares are currently priced at $41.77, which is +0.1% above the low and -3.8% below the high.
The Rigel Pharmaceuticals(RIGL)'s current trading volume is 420.86K, compared to an average daily volume of 488.57K.
During the past year, Rigel Pharmaceuticals(RIGL) stock moved between $14.63 at its lowest and $52.24 at its peak.
During the past year, Rigel Pharmaceuticals(RIGL) stock moved between $14.63 at its lowest and $52.24 at its peak.
People also own
Based on the portfolios of people who own RIGL. This list is generated using Robinhood data, and it’s not a recommendation.